港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

1,638.656

-35.111-2.10%

涨家数：1

跌家数：7

平家数：- -

市盈率：- -

高：1,674.069

开：1,674.069

低：1,601.346

收：1,673.767

数据加载中...

总览新闻资讯

泰格医药盘中异动股价大跌5.05%

药明生物(02269)出现大手买入22.9万股，成交价$22.45，涉资514.105万

阿斯达克财经

开拓药业(09939.HK)治疗雄激素性脱发药物临床试验达主要研究终点

阿斯达克财经

17亿港元！高瓴资本清仓金斯瑞蓬勃生物

泰格医药回购股份方案实施期限届满

泰格医药：本次回购股份方案的实施期限已届满

证券日报网

药明生物(02269)因期权获行使发行26.1万股

康宁杰瑞制药-B(09966)：KN026关键性II/III期临床试验期中分析达到PFS主要终点

药明康德：1Q25业绩显著好于预期，维持全年指引

浦银国际研究

易方达基金增持泰格医药(03347)19.18万股每股作价约26.98港元

泰格医药截至4月末累计回购A股980.63万股

泰格医药(03347)截至4月末累计回购A股980.63万股

4月30日康龙化成AH溢价达83.29%，位居AH股溢价率第53位

药明康德04月30日主力净流出2825.5万元散户资金买入

药明生物04月30日遭主力抛售2179.3万元

泰格医药04月30日主力净流入310.8万元散户资金抛售

康龙化成04月30日主力净流出170.3万元散户资金买入

默沙东研发（中国）有限公司药品申请临床试验默示许可获受理

北京泰德制药股份有限公司药品申请临床试验默示许可获受理

高盛：上调药明康德目标价至74.9港元上调2025至27年纯利预测

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1576/news?page=5&region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":1638.6559,"timestamp":1747021940839,"preClose":1673.7673,"halted":0,"volume":65244219,"delay":0,"changeRate":-0.020977,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-35.11145,"latestTime":"05-12 11:52:22","open":1674.0686,"high":1674.0686,"low":1601.3455,"amount":1351734573,"amplitude":0.043449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1747022400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"pbRate":1.995923,"peRate":9.57354,"turnoverRate":0.005763,"increases":1,"decrements":7,"flats":0,"marketCap":350425120256,"floatMarketCap":151772221696},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1674.0686,"amplitude":0.043449,"preClose":1673.7673,"low":1601.3455,"pbRate":"1.995923","latestPrice":1638.6559,"volume":65244219,"delay":0,"open":1674.0686,"prevYearClose":1395.7731,"prevWeekClose":1673.767,"prevMonthClose":1656.921,"prevQuarterClose":1941.338,"fiveDayClose":1741.969,"twentyDayClose":1361.109,"sixtyDayClose":1618.242,"secType":"PLATE","market":"HK","turnoverRate":0.005763,"peRate":9.57354,"marketCap":350425120256,"floatMarketCap":151772221696,"timestamp":1747021940839,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":1,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532185132","title":"泰格医药盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532185132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532185132?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 09:49","pubTimestamp":1746150576,"startTime":"0","endTime":"0","summary":"2025年05月02日早盘09时49分，泰格医药股票出现异动，股价大幅下挫5.05%。泰格医药股票所在的生物技术行业中，整体跌幅为1.45%。该信息摘要如下：消息面上，4月28日，泰格医药发布公告，于2025年第一季度，该集团取得营业收入15.64亿元，同比减少5.79%;归属于上市公司股东的净利润1.65亿元，同比减少29.61%;基本每股收益0.19元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502094936a6d09c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502094936a6d09c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2532602859","title":"药明生物(02269)出现大手买入22.9万股，成交价$22.45，涉资514.105万","url":"https://stock-news.laohu8.com/highlight/detail?id=2532602859","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532602859?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 09:35","pubTimestamp":1746149700,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午09:35出现大手买入，成交量为22.9万，成交价为港币$22.45，涉资514.105万。至目前为止，股价跌1.754%，今日最高价为$22.9，而最低价为$22.4，总成交量为411.407万股，总成交金额港币$9.301千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT250502731/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0856984785.SGD","LU0819121731.USD","LU0516422952.EUR","LU1794554557.SGD","LU1242518857.USD","LU1242518931.SGD","LU0516423091.SGD","LU0588546209.SGD","LU0327786744.USD","LU1688375341.USD","LU0359202008.SGD","SG9999002463.SGD","LU0140636845.USD","BK1141","02269","LU0181495838.USD","LU0708995583.HKD","LU1720050803.USD","LU0039217434.USD","SG9999002562.SGD","LU0823426308.USD","LU0516422440.USD","LU0516423174.USD","LU0823426480.USD","IE00B0JY6N72.USD","LU0052750758.USD","LU0417516738.SGD","LU0456827905.SGD","LU0456846285.SGD","LU0979878070.USD","LU0320764599.SGD","LU0051755006.USD","LU0348825331.USD","BK1610","LU0326950275.SGD","LU0572944931.SGD","LU2039709279.SGD","LU0359201612.USD","BK1589","LU0417516902.SGD","BK1521","LU0043850808.USD","LU0307460666.USD","LU0348735423.USD","LU1880383366.USD","LU0516422366.SGD","BK1576"],"gpt_icon":0},{"id":"2532589418","title":"开拓药业(09939.HK)治疗雄激素性脱发药物临床试验达主要研究终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532589418","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532589418?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 08:14","pubTimestamp":1746144840,"startTime":"0","endTime":"0","summary":"开拓药业-B(09939.HK) 公布，KX-826与米诺地尔联合治疗中国成年男性雄激素性脱发的Ib/III期临床试验，已达到主要研究终点。公告指，上述临床观察试验是一项开放标签、随机对照研究，旨在评估KX-826联合米诺地尔外用治疗中国成年男性脱发的有效性和安全性，并基于试验结果，优化未来正式III期临床试验方案设计，包括剂量选择、入组患者数量等关键要素.。开拓药业表示，基于该研究成果，公司对已获专利授权的联合疗法治疗潜力更具信心，后续将有序推进III期临床试验。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220721143639401_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220721143639401_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1437431/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","09939","03347","BK1576","BK1161","BK1515","BK1141","BK1583"],"gpt_icon":0},{"id":"2532832723","title":"17亿港元！高瓴资本清仓金斯瑞蓬勃生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2532832723","media":"药事纵横","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532832723?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 07:02","pubTimestamp":1746140559,"startTime":"0","endTime":"0","summary":"4月28日，金斯瑞发布公告宣布金斯瑞蓬勃生物发生股权转让，高瓴资本及其联合体持有的蓬勃生物3亿股A类优先股将以约17亿港元转让给金斯瑞及其全资控股子公司，股权转让基于蓬勃生物整体估值16.84亿美元。截至4月28日收盘，金斯瑞股价报11.14港元，年初至今累计涨幅约12.98%，市值约241.63亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502071117a6d0809d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502071117a6d0809d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348825331.USD","LU0431992006.USD","LU0865486749.SGD","LU1044876610.USD","LU1366334651.USD","LU0469268626.HKD","LU0052750758.USD","BK1583","LU0140636845.USD","LU0417516902.SGD","LU0572944931.SGD","LU1770034418.SGD","LU2039709279.SGD","LU1282651121.HKD","LU0149721374.USD","LU0456842615.SGD","LU0051755006.USD","IE00BGV7N243.SGD","LU0588545490.SGD","BK1141","LU1282649810.SGD","IE0032431581.USD","IE00B3M56506.USD","LU0543330483.HKD","89618","LU0499858602.USD","LU2242644610.SGD","IE00B29SXG58.USD","01548","LU0307460666.USD","LU0315178854.USD","LU0868486357.SGD","BK1576","HK0000320264.USD","LU0345776255.USD","LU0588546209.SGD","LU1328277881.USD","LU1481107354.HKD","BK1575","LU0228659784.USD","LU0417516738.SGD","LU0791590937.USD","LU0791591158.USD","LU0164880469.USD","LU0048580855.USD","LU0650527681.SGD","LU0384037296.USD","LU0211977185.USD"],"gpt_icon":1},{"id":"2531052981","title":"泰格医药回购股份方案实施期限届满","url":"https://stock-news.laohu8.com/highlight/detail?id=2531052981","media":"DoNews","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531052981?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 23:16","pubTimestamp":1746026161,"startTime":"0","endTime":"0","summary":"4月30日，泰格医药发布公告称，公司回购股份方案实施期限已届满。截至当日，通过集中竞价交易方式累计回购9,806,300股，占总股本1.1337%。此举旨在优化资本结构并维护股东利益。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043023242594e91e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043023242594e91e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2531051005","title":"泰格医药：本次回购股份方案的实施期限已届满","url":"https://stock-news.laohu8.com/highlight/detail?id=2531051005","media":"证券日报网","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531051005?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 22:10","pubTimestamp":1746022200,"startTime":"0","endTime":"0","summary":"证券日报网讯4月30日晚间，泰格医药发布公告称，截至本公告日，公司本次回购股份方案的实施期限已届满，截至2025年4月30日，公司股份回购专用证券账户以集中竞价交易方式累计回购公司股份9，806，300股，占公司总股本的比例为1.1337%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-30/doc-ineuyhur3986133.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-30/doc-ineuyhur3986133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","BK0077","BK0028","BK1141","BK1576","BK0174","BK0216","LU1146622755.USD","300347","BK1583","LU1820825898.SGD"],"gpt_icon":0},{"id":"2531037318","title":"药明生物(02269)因期权获行使发行26.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531037318","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531037318?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 20:58","pubTimestamp":1746017914,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明生物(02269)发布公告，于2025年4月30日，根据公司于2016年1月5日采纳的首次公开发售前购股权计划(于2016年8月10日修订)为行使期权而发行26.1万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0516423174.USD","LU0979878070.USD","SG9999002562.SGD","LU0327786744.USD","LU0052750758.USD","LU0348825331.USD","LU0819121731.USD","LU0823426308.USD","LU0043850808.USD","LU0051755006.USD","LU0181495838.USD","LU0348735423.USD","LU0516422952.EUR","LU0708995583.HKD","LU0456846285.SGD","LU1880383366.USD","BK1521","LU0320764599.SGD","02269","IE00B0JY6N72.USD","LU1242518931.SGD","LU0516423091.SGD","LU0456827905.SGD","LU1688375341.USD","LU0417516902.SGD","LU0417516738.SGD","LU0039217434.USD","LU1720050803.USD","BK1589","LU1242518857.USD","LU2039709279.SGD","LU0588546209.SGD","LU0326950275.SGD","LU0140636845.USD","LU0572944931.SGD","BK1141","BK1610","LU0516422440.USD","SG9999002463.SGD","LU0823426480.USD","LU0516422366.SGD","LU0307460666.USD","LU0359202008.SGD","LU0359201612.USD","LU1794554557.SGD","BK1576","LU0856984785.SGD"],"gpt_icon":0},{"id":"2531035965","title":"康宁杰瑞制药-B(09966)：KN026关键性II/III期临床试验期中分析达到PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035965","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035965?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B 发布公告，本公司与石药集团有限公司附属公司上海津曼特生物科技有限公司合作开发的KN026联合化疗二线及以上治疗HER2阳性GC的II/III期临床试验已完成首个期中分析及期中分析结果达到PFS主要终点。KN026-001研究第2部分的首个PFS期中分析结果已由独立数据监察委员会 审查，结果显示达到预先设定的PFS的主要终点，具有统计学显著性和临床意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1141","BK4195","PFS","BK1576","BK1161","III","BK4134","BK1583","BK4211","BK1574","03347"],"gpt_icon":0},{"id":"2531328032","title":"药明康德：1Q25业绩显著好于预期，维持全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2531328032","media":"浦银国际研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531328032?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010817,"startTime":"0","endTime":"0","summary":"浦银国际研究公司1Q25业绩显著好于预期，主要由于小分子D&M收入和TIDES业务收入显著好于我们和市场预期。管理层表示，1Q25持续经营业务新签订单增速约为25% YoY。图表以上内容节选自浦银国际证券于2025年4月30日发布的研究报告《药明康德：1Q25业绩显著好于预期，维持全年指引》，欲览报告详情，请点击下方阅读原文。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430204234a6ceddd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430204234a6ceddd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0052750758.USD","LU2125910500.SGD","BK1576","LU1046422090.SGD","02359","LU2045819591.USD","LU0320764599.SGD","BK1583","LU0708995583.HKD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2531082764","title":"易方达基金增持泰格医药(03347)19.18万股 每股作价约26.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531082764","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531082764?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 18:31","pubTimestamp":1746009071,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月25日，易方达基金增持泰格医药(03347)19.18万股，每股作价26.9807港元，总金额约为517.49万港元。增持后最新持股数目为871.81万股，持股比例为7.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1146622755.USD","BK0028","BK0216","LU1820825898.SGD","BK0174","BK0077","BK1583","03347","300347","BK1576","BK1141"],"gpt_icon":0},{"id":"2531758084","title":"泰格医药截至4月末累计回购A股980.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758084","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531758084?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 18:04","pubTimestamp":1746007440,"startTime":"0","endTime":"0","summary":"泰格医药(03347)发布公告，截至2025年4月30日，公司股份回购专用证券账户...泰格医药(03347)发布公告，截至2025年4月30日，公司股份回购专用证券账户以集中竞价交易方式累计回购公司股份980.63万股，占公司总股本的比例为1.1337%，占公司A股总股本比例为1.3219%，最高成交价为62.00元/股，最低成交价为48.17元/股，成交总金额为5亿元(不含交易费用)。公告称，公司本次实际回购资金总额已超过回购方案中的回购资金总额下限，且未超过回购资金总额上限，公司本次回购股份方案已实施完毕。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043018071194e8d2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043018071194e8d2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2531839190","title":"泰格医药(03347)截至4月末累计回购A股980.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531839190","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531839190?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 17:28","pubTimestamp":1746005305,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，截至2025年4月30日，公司股份回购专用证券账户以集中竞价交易方式累计回购公司股份980.63万股，占公司总股本的比例为1.1337%，占公司A股总股本比例为1.3219%，最高成交价为62.00元/股，最低成交价为48.17元/股，成交总金额为5亿元(不含交易费用)。公告称，公司本次实际回购资金总额已超过回购方案中的回购资金总额下限，且未超过回购资金总额上限，公司本次回购股份方案已实施完毕。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU1820825898.SGD","300347","BK1583","BK0028","399300","LU1146622755.USD","159982","BK0174","03347","BK0216","BK1576","BK0077"],"gpt_icon":0},{"id":"2531070703","title":"4月30日康龙化成AH溢价达83.29%，位居AH股溢价率第53位","url":"https://stock-news.laohu8.com/highlight/detail?id=2531070703","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531070703?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:43","pubTimestamp":1746002634,"startTime":"0","endTime":"0","summary":"4月30日，上证指数跌0.23%，收报3279.03点，恒生指数涨0.51%，收报22119.41点。当日收盘，康龙化成A股报23.17元，跌幅1.49%，H股报13.5港元，下跌1.32%。资料显示，康龙化成(北京)新药技术股份有限公司是生命科学行业的主要服务提供商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043016480994e8baa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043016480994e8baa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03759","BK1576"],"gpt_icon":0},{"id":"2531085455","title":"药明康德04月30日主力净流出2825.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531085455?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000947,"startTime":"0","endTime":"0","summary":"04月30日, 药明康德股价跌0.82%，报收60.15元，成交金额4.6亿元，换手率1.98%，振幅4.45%，量比0.77。药明康德今日主力资金净流出2825.5万元，上一交易日主力净流入6330.4万元。该股近5个交易日上涨3.22%，主力资金累计净流入7019.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4.4亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171248a46d7629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171248a46d7629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","LU2045819591.USD","LU0708995583.HKD","LU0320764599.SGD","BK1576","02359","BK1583","BK1141","LU2125910500.SGD","LU1046422090.SGD","LU0052750758.USD"],"gpt_icon":0},{"id":"2531833130","title":"药明生物04月30日遭主力抛售2179.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531833130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531833130?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000935,"startTime":"0","endTime":"0","summary":"04月30日, 药明生物股价跌1.30%，报收22.80元，成交金额5.2亿元，换手率0.55%，振幅3.46%，量比0.53。药明生物今日主力资金净流出2179.3万元，连续5日净流出，上一交易日主力净流出5356.7万元。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为100.00%，平均跌幅为1.50%。该股近5个交易日上涨1.10%，主力资金累计净流出1.5亿元；近20日主力资金累计净流出5.5亿元，其中净流出天数为14日。该股主力净额占比0.02%，港股市场排名2518/2646。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170833a46d74a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170833a46d74a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0181495838.USD","LU0823426480.USD","LU0140636845.USD","LU0359202008.SGD","LU0516422952.EUR","LU0856984785.SGD","LU0979878070.USD","LU0417516738.SGD","LU1794554557.SGD","LU0823426308.USD","LU1242518857.USD","LU0516423174.USD","LU0359201612.USD","LU1880383366.USD","LU0516423091.SGD","LU0708995583.HKD","SG9999002562.SGD","LU0307460666.USD","BK1589","LU0043850808.USD","LU0326950275.SGD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0819121731.USD","LU0051755006.USD","BK1141","LU0320764599.SGD","LU0327786744.USD","LU2039709279.SGD","LU0456827905.SGD","LU0456846285.SGD","BK1610","LU1720050803.USD","LU0348735423.USD","02269","LU0039217434.USD","LU0348825331.USD","LU0417516902.SGD","LU0052750758.USD","LU1688375341.USD","LU1242518931.SGD","LU0516422366.SGD","BK1521","LU0572944931.SGD","SG9999002463.SGD","LU0516422440.USD"],"gpt_icon":1},{"id":"2531238085","title":"泰格医药04月30日主力净流入310.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531238085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531238085?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000925,"startTime":"0","endTime":"0","summary":"04月30日, 泰格医药股价涨3.48%，报收26.75元，成交金额4912.0万元，换手率1.50%，振幅3.68%，量比0.73。泰格医药今日主力资金净流入310.8万元，上一交易日主力净流出553.8万元。该股主力净额占比0.09%，港股市场排名77/2646。|04月30日主力加仓幅度排名||#|股票简称|主力净额占比|#|中国宏光|1.15%|#|中天湖南集团|1.03%|#|立德教育|1.00%|#|...|...|#76|泰格医药|0.09%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170521a46d7366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170521a46d7366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2531707032","title":"康龙化成04月30日主力净流出170.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531707032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531707032?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000916,"startTime":"0","endTime":"0","summary":"04月30日, 康龙化成股价跌1.32%，报收13.50元，成交金额5016.6万元，换手率1.26%，振幅3.07%，量比0.54。康龙化成今日主力资金净流出170.3万元，上一交易日主力净流入75.0万元。该股近5个交易日上涨2.12%，主力资金累计净流出1703.4万元；近20日主力资金累计净流出8151.3万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170348a6ce9862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170348a6ce9862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1141","BK1576"],"gpt_icon":0},{"id":"2531703906","title":"默沙东研发（中国）有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703906","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531703906?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 15:27","pubTimestamp":1745998045,"startTime":"0","endTime":"0","summary":"4月30日，据CDE官网消息，默沙东研发（中国）有限公司联合申请药品“注射用MK-2870”，获得临床试验默示许可，受理号CXSB2500040。公示信息显示，药品“注射用MK-2870”适应症：非小细胞肺癌。默沙东研发（中国）有限公司，成立于2012年，位于北京市，是一家以从事研究和试验发展为主的企业。企业注册资本2000万美元，实缴资本2000万美元。通过天眼查大数据分析，默沙东研发（中国）有限公司参与招投标项目9次，专利信息3条，此外企业还拥有行政许可7个。主要股东信息显示，默沙东研发（中国）有限公司由默沙东研发有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30152750039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4534","IE00BFTCPJ56.SGD","BK4588","LU0070302665.USD","LU0122379950.USD","LU0965508806.USD","LU1066053197.SGD","IE00BLSP4452.SGD","SG9999014567.USD","LU0965509283.SGD","LU1974910355.USD","LU1057294990.SGD","LU1430594728.SGD","LU2023250504.SGD","LU2023250843.SGD","SG9999001176.USD","IE00B1BXHZ80.USD","SG9999014542.SGD","LU1989772840.SGD","LU0265550359.USD","LU1093756325.SGD","BK1576","LU1291159041.SGD","SG9999002224.SGD","LU0106261372.USD","LU1116320737.USD","BK4585","BK4533","LU1941712264.USD","MRK","LU1917777945.USD","SG9999014575.USD","LU2461242641.AUD","LU0203347892.USD","LU1571399168.USD","LU1023059063.AUD","LU1066051811.HKD","LU1941712348.USD","LU0058720904.USD","LU2089984988.USD","03347","LU0289739699.SGD","IE00BN8TJ469.HKD","BK4007","LU0861579265.USD","LU1037948897.HKD","LU0320765646.SGD","LU0211331839.USD","LU1035773651.USD","BK4516"],"gpt_icon":0},{"id":"2531039287","title":"北京泰德制药股份有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039287","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039287?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 15:27","pubTimestamp":1745998045,"startTime":"0","endTime":"0","summary":"4月30日，据CDE官网消息，北京泰德制药股份有限公司联合申请药品“TCC1727片”，获得临床试验默示许可，受理号CXHL2500225。公示信息显示，药品“TCC1727片”适应症：本品适用于联合贝莫苏拜单抗注射液、奥拉帕利片或化疗治疗晚期实体瘤。北京泰德制药股份有限公司，成立于1995年，位于北京市，是一家以从事医药制造业为主的企业。企业注册资本50000万人民币，实缴资本50000万人民币。通过天眼查大数据分析，北京泰德制药股份有限公司共对外投资了13家企业，参与招投标项目5000次，知识产权方面有商标信息386条，专利信息213条，此外企业还拥有行政许可108个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30152750039948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK1191","BK1574","BK1141","BK1583","01477","03347"],"gpt_icon":0},{"id":"2531507720","title":"高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2531507720","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531507720?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 12:41","pubTimestamp":1745988074,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00B19Z3B42.SGD","BK1141","BK4585","BK1583","LU2237443978.SGD","LU2045819591.USD","LU2237443622.USD","BK4533","BK4127","LU0096364046.USD","BK0216","BK4550","LU2471134952.CNY","LU0742534661.SGD","603259","LU1868836914.USD","LU2237443895.HKD","LU2471134523.USD","LU1997245177.USD","IE00B19Z3581.USD","LU1791807156.HKD","BK4552","LU1868837136.USD","LU2237443465.HKD","LU0708995583.HKD","LU1868837300.USD","LU2237438978.USD","IE0004086264.USD","LU2471134879.HKD","LU0106831901.USD","LU1668664300.SGD","LU2237443382.USD","LU1868836757.USD","02359","LU2750360997.AUD","BK4516","LU0251131958.USD","LU1997244956.HKD","LU0048573561.USD","BK1576","LU0320764599.SGD","IE00BSNM7G36.USD","LU0251142724.SGD","LU2488822045.USD","LU2242644610.SGD","LU1046422090.SGD","LU1997245094.SGD","IE0034235188.USD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":186,"code":"91000000","status":"200"}]}}